{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-266161","form_type":"8-K","ticker":"MDXG","cik":"0001376339","company_name":"MIMEDX GROUP, INC.","filed_at":"2023-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.798750+00:00","generated_at":"2026-06-09T05:44:28.132505+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"MiMedx Q3 net sales up 20.7% to $81.7M, GAAP net income $8.5M, raises FY outlook","bullets":["Q3 net sales $81.7M (+20.7% YoY); GAAP net income $8.5M vs loss $8.4M prior year.","Adjusted EBITDA $17.6M (21.6% margin) vs $2.4M; cash from ops $12.8M.","Raised FY2023 net sales growth outlook to high teens; expects H2 Adj. EBITDA margin >20%.","Repurchased $9.5M of Series B Preferred Stock from Hayfin; one-year lock-up.","Cash $81.2M, up from $66.0M at Dec 31, 2022; long-term debt $49.0M."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-266161","json":"https://secwatch.observer/filing/0001193125-23-266161.json","markdown":"https://secwatch.observer/filing/0001193125-23-266161.md","text":"https://secwatch.observer/filing/0001193125-23-266161.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1376339/000119312523266161/0001193125-23-266161-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1376339/000119312523266161/d570687d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T05:44:28.132505+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"52e1bd5e5d329ba40fdc3a536123f9d026071b3b","claim":"MIMEDX GROUP, INC. reported the third quarter ended September 30, 2023 results: revenue $81.7 million, net income $8.5 million. Guidance raised.","evidence_excerpt":"operating and financial results for the third quarter 2023, which ended September 30, 2023. Recent Operating and Financial Highlights: • Third quarter 2023 net sales of $81.7 million, an increase of 20.7% over third quarter 2022. • GAAP net income of $8.5 million for third quarter 2023. • Adjusted EBITDA 1 of $17.6 million for third quarter 2023, representing","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1376339/000119312523266161/0001193125-23-266161-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter ended September 30, 2023"},{"label":"Revenue","value":"$81.7 million"},{"label":"Net income","value":"$8.5 million"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}